Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jacot

Showing results (41-50 of 212) with videos related to

Pageof 22
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 2, 2025
Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group)Gabriel Antherieu, Vincent Thibaud, Pierre Sesques, et al.
Cancers|September 23, 2020
Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant ChemotherapyIleana Corbeau, Simon Thezenas, Aurelie Maran-Gonzalez, et al.
Frontiers in Immunology|December 22, 2022
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancerFlorence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, et al.
La Revue Du Praticien|July 26, 2003
[Small cell lung carcinoma]Jean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Breast (Edinburgh, Scotland)|July 9, 2013
Prognostic factors of brain metastases from breast cancer: impact of targeted therapiesAntoine Laurent Braccini, David Azria, Simon Thezenas, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2010
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective studyKais Aldabbagh, Stéphane Pouderoux, Lise Roca, et al.
Breast Cancer Research and Treatment|January 16, 2021
Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patientsLeticia Aptecar, Frederic Fiteni, Marta Jarlier, et al.
Scientific Reports|March 11, 2025
Impact of adapted physical activity and diet counselling on health-related quality of life in women undergoing adjuvant breast cancer therapyCélia Touraine, William Jacot, Sophie Gourgou, et al.
International Journal of Cancer|July 1, 2021
Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancerAmélie Darlix, Christophe Hirtz, Caroline Mollevi, et al.
BMJ Open|January 8, 2024
Efficacy of a physiotherapy, yoga and patient education programme for patients with breast cancer and hormone therapy-induced pain: a multicentre randomised study protocol (SKYPE 2)Kerstin Faravel, Marta Jarlier, Laetitia Meignant, et al.
Pageof 22

Showing results (41-50 of 212) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 2, 2025
Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group)Gabriel Antherieu, Vincent Thibaud, Pierre Sesques, et al.
Cancers|September 23, 2020
Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant ChemotherapyIleana Corbeau, Simon Thezenas, Aurelie Maran-Gonzalez, et al.
Frontiers in Immunology|December 22, 2022
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancerFlorence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, et al.
La Revue Du Praticien|July 26, 2003
[Small cell lung carcinoma]Jean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Breast (Edinburgh, Scotland)|July 9, 2013
Prognostic factors of brain metastases from breast cancer: impact of targeted therapiesAntoine Laurent Braccini, David Azria, Simon Thezenas, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2010
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective studyKais Aldabbagh, Stéphane Pouderoux, Lise Roca, et al.
Breast Cancer Research and Treatment|January 16, 2021
Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patientsLeticia Aptecar, Frederic Fiteni, Marta Jarlier, et al.
Scientific Reports|March 11, 2025
Impact of adapted physical activity and diet counselling on health-related quality of life in women undergoing adjuvant breast cancer therapyCélia Touraine, William Jacot, Sophie Gourgou, et al.
International Journal of Cancer|July 1, 2021
Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancerAmélie Darlix, Christophe Hirtz, Caroline Mollevi, et al.
BMJ Open|January 8, 2024
Efficacy of a physiotherapy, yoga and patient education programme for patients with breast cancer and hormone therapy-induced pain: a multicentre randomised study protocol (SKYPE 2)Kerstin Faravel, Marta Jarlier, Laetitia Meignant, et al.
Pageof 22